Anticancer Platinum Drugs Update
Open Access
- 4 November 2021
- journal article
- editorial
- Published by MDPI AG in Biomolecules
- Vol. 11 (11) , 1637
Abstract
The discovery of the anticancer properties of platinum derivatives by Rosenberg represents a milestone in the development of chemotherapeutic protocols for tumor treatmentKeywords
This publication has 17 references indexed in Scilit:
- The side effects of platinum-based chemotherapy drugs: a review for chemistsDalton Transactions, 2018
- Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced OtotoxicityPharmacogenomics, 2015
- Molecular Pathways: The Immunogenic Effects of Platinum-Based ChemotherapeuticsClinical Cancer Research, 2014
- Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Proceedings of the National Academy of Sciences, 2013
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective InterventionsThe American Journal of Pathology, 2010
- Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2The American Journal of Pathology, 2005
- Curing metastatic testicular cancerProceedings of the National Academy of Sciences, 2002
- Platinum coordination complexes in cancer chemotherapyThe Science of Nature, 1973
- The successful regression of large solid sarcoma 180 tumors by platinum compounds.1970
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969